Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

The population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary.

Papp V, Iljicsov A, Rajda C, Magyari M, Koch-Henriksen N, Petersen T, Jakab G, Deme I, Nagy F, Imre P, Lohner Z, Kovács K, Birkás AJ, Köves Á, Rum G, Nagy Z, Kerényi L, Vécsei L, Bencsik K, Jobbágy Z, Diószeghy P, Horváth L, Galántai G, Kasza J, Molnár G, Simó M, Sátori M, Rózsa C, Ács P, Berki T, Lovas G, Komoly S, Illes Z.

Eur J Neurol. 2019 Aug 29. doi: 10.1111/ene.14079. [Epub ahead of print]

PMID:
31465603
2.

Retraction Note: Unique RNA signature of different lesion types in the brain white matter in progressive multiple sclerosis.

Elkjaer ML, Frisch T, Reynolds R, Kacprowski T, Burton M, Kruse TA, Thomassen M, Baumbach J, Illes Z.

Acta Neuropathol Commun. 2019 Aug 21;7(1):136. doi: 10.1186/s40478-019-0790-7.

3.

Immunological Aspects of Approved MS Therapeutics.

Rommer PS, Milo R, Han MH, Satyanarayan S, Sellner J, Hauer L, Illes Z, Warnke C, Laurent S, Weber MS, Zhang Y, Stuve O.

Front Immunol. 2019 Jul 11;10:1564. doi: 10.3389/fimmu.2019.01564. eCollection 2019. Review.

4.

Prediction of students' awareness level towards ICT and mobile technology in Indian and Hungarian University for the real-time: preliminary results.

Verma C, Stoffová V, Illés Z.

Heliyon. 2019 Jun 18;5(6):e01806. doi: 10.1016/j.heliyon.2019.e01806. eCollection 2019 Jun.

5.

Unique RNA signature of different lesion types in the brain white matter in progressive multiple sclerosis.

Elkjaer ML, Frisch T, Reynolds R, Kacprowski T, Burton M, Kruse TA, Thomassen M, Baumbach J, Illes Z.

Acta Neuropathol Commun. 2019 Apr 25;7(1):58. doi: 10.1186/s40478-019-0709-3. Retraction in: Acta Neuropathol Commun. 2019 Aug 21;7(1):136.

6.

[Cognitive dysfunction, loss of visual acuity and hearing can be symptoms of Susac syndrome].

Søgaard LE, Illes Z, Nguyen N, Byg KE.

Ugeskr Laeger. 2019 Apr 8;181(15). pii: V06180437. Danish.

PMID:
30990159
7.

L-arginine pathway metabolites can discriminate paroxysmal from permanent atrial fibrillation in acute ischemic stroke.

Csecsei P, Várnai R, Nagy L, Kéki S, Molnár T, Illés Z, Farkas N, Szapáry L.

Ideggyogy Sz. 2019 Mar 30;72(3-4):79-88. doi: 10.18071/isz.72.0079.

PMID:
30957461
8.

Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study.

Buron MD, Chalmer TA, Sellebjerg F, Frederiksen J, Góra MK, Illes Z, Kant M, Mezei Z, Petersen T, Rasmussen PV, Roshanisefat H, Hassanpour-Kalam-Roudy H, Sejbæk T, Tsakiri A, Weglewski A, Sorensen PS, Magyari M.

Neurology. 2019 Apr 16;92(16):e1811-e1820. doi: 10.1212/WNL.0000000000007314. Epub 2019 Mar 15.

PMID:
30877188
9.

Subacute Elevation of Plasma Level of Caspase-Cleaved Cytokeratin-18 is Associated with Hemorrhagic Transformation and Functional Outcome in Ischemic Stroke.

Molnar T, Borocz K, Berki T, Szapary L, Szolics A, Janszky J, Illes Z, Csecsei P.

J Stroke Cerebrovasc Dis. 2019 Mar;28(3):719-727. doi: 10.1016/j.jstrokecerebrovasdis.2018.11.015. Epub 2018 Dec 5.

PMID:
30528602
10.

Ictal piloerection is associated with high-grade glioma and autoimmune encephalitis-Results from a systematic review.

Tényi D, Bóné B, Horváth R, Komoly S, Illés Z, Beier CP, Kelemen A, Kovács N, Darnai G, Janszky J.

Seizure. 2019 Jan;64:1-5. doi: 10.1016/j.seizure.2018.11.009. Epub 2018 Nov 22.

PMID:
30497014
11.

Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.

Papp V, Illes Z, Magyari M, Koch-Henriksen N, Kant M, Pfleger CC, Roemer SF, Jensen MB, Petersen AE, Nielsen HH, Rosendahl L, Mezei Z, Christensen T, Svendsen K, Hyldgaard Jensen PE, Lydolph MC, Heegaard N, Frederiksen JL, Sellebjerg F, Stenager E, Petersen T.

Neurology. 2018 Dec 11;91(24):e2265-e2275. doi: 10.1212/WNL.0000000000006645. Epub 2018 Nov 9.

12.

Acute and delayed effects of concentric and eccentric exercise on quantitative muscle MRI.

Nagy SA, Váczi M, Perlaki G, Orsi G, Illés Z, Bogner P.

Acta Radiol. 2019 Jul;60(7):902-907. doi: 10.1177/0284185118801171. Epub 2018 Sep 18. No abstract available.

PMID:
30227725
13.

Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes.

Martin NA, Nawrocki A, Molnar V, Elkjaer ML, Thygesen EK, Palkovits M, Acs P, Sejbaek T, Nielsen HH, Hegedus Z, Sellebjerg F, Molnar T, Barbosa EGV, Alcaraz N, Gallyas F Jr, Svenningsen AF, Baumbach J, Lassmann H, Larsen MR, Illes Z.

PLoS One. 2018 Aug 16;13(8):e0202530. doi: 10.1371/journal.pone.0202530. eCollection 2018.

14.

Real-life persistence and tolerability with dimethyl fumarate.

Sejbaek T, Nybo M, Petersen T, Illes Z.

Mult Scler Relat Disord. 2018 Aug;24:42-46. doi: 10.1016/j.msard.2018.05.007. Epub 2018 Jun 2.

PMID:
29906666
15.

Omics-Based Approach Reveals Complement-Mediated Inflammation in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS).

Blaabjerg M, Hemdrup AL, Drici L, Ruprecht K, Garred P, Höftberger R, Kristensen BW, Kondziella D, Sejbaek T, Hansen SW, Nielsen HH, Jensen P, Meyer M, Paul F, Lassmann H, Larsen MR, Illes Z.

Front Immunol. 2018 Apr 23;9:741. doi: 10.3389/fimmu.2018.00741. eCollection 2018.

16.

Experimental Demyelination and Axonal Loss Are Reduced in MicroRNA-146a Deficient Mice.

Martin NA, Molnar V, Szilagyi GT, Elkjaer ML, Nawrocki A, Okarmus J, Wlodarczyk A, Thygesen EK, Palkovits M, Gallyas F Jr, Larsen MR, Lassmann H, Benedikz E, Owens T, Svenningsen AF, Illes Z.

Front Immunol. 2018 Mar 12;9:490. doi: 10.3389/fimmu.2018.00490. eCollection 2018.

17.

Management of multiple sclerosis patients in central European countries: current needs and potential solutions.

Berger T, Adamczyk-Sowa M, Csépány T, Fazekas F, Hojs Fabjan T, Horáková D, Illes Z, Klimová E, Leutmezer F, Rejdak K, Rozsa C, Šega Jazbec S, Szilasiová J, Turčáni P, Vachová M, Vécsei L, Havrdová E.

Ther Adv Neurol Disord. 2018 Feb 22;11:1756286418759189. doi: 10.1177/1756286418759189. eCollection 2018. Review.

18.

Relationship between Cardiac Troponin and Thrombo-Inflammatory Molecules in Prediction of Outcome after Acute Ischemic Stroke.

Csecsei P, Pusch G, Ezer E, Berki T, Szapary L, Illes Z, Molnar T.

J Stroke Cerebrovasc Dis. 2018 Apr;27(4):951-956. doi: 10.1016/j.jstrokecerebrovasdis.2017.10.040. Epub 2017 Dec 14.

PMID:
29249591
19.

Cerebrospinal fluid findings in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathies.

Illes Z, Blaabjerg M.

Handb Clin Neurol. 2017;146:125-138. doi: 10.1016/B978-0-12-804279-3.00009-5. Review.

PMID:
29110767
20.

Long-term structural retinal changes in patients with optic neuritis related to multiple sclerosis.

Andersen MR, Roar M, Sejbaek T, Illes Z, Grauslund J.

Clin Ophthalmol. 2017 Aug 17;11:1519-1525. doi: 10.2147/OPTH.S142206. eCollection 2017.

21.

Macrophage migration inhibitory factor (MIF) modulates trophic signaling through interaction with serine protease HTRA1.

Fex Svenningsen Å, Löring S, Sørensen AL, Huynh HUB, Hjæresen S, Martin N, Moeller JB, Elkjær ML, Holmskov U, Illes Z, Andersson M, Nielsen SB, Benedikz E.

Cell Mol Life Sci. 2017 Dec;74(24):4561-4572. doi: 10.1007/s00018-017-2592-z. Epub 2017 Jul 19.

22.

Fumarate decreases edema volume and improves functional outcome after experimental stroke.

Clausen BH, Lundberg L, Yli-Karjanmaa M, Martin NA, Svensson M, Alfsen MZ, Flæng SB, Lyngsø K, Boza-Serrano A, Nielsen HH, Hansen PB, Finsen B, Deierborg T, Illes Z, Lambertsen KL.

Exp Neurol. 2017 Sep;295:144-154. doi: 10.1016/j.expneurol.2017.06.011. Epub 2017 Jun 8.

PMID:
28602832
23.

Changes to the septo-fornical area might play a role in the pathogenesis of anxiety in multiple sclerosis.

Palotai M, Mike A, Cavallari M, Strammer E, Orsi G, Healy BC, Schregel K, Illes Z, Guttmann CR.

Mult Scler. 2018 Jul;24(8):1105-1114. doi: 10.1177/1352458517711273. Epub 2017 May 26.

PMID:
28548605
24.

Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.

Celicanin M, Blaabjerg M, Maersk-Moller C, Beniczky S, Marner L, Thomsen C, Bach FW, Kondziella D, Andersen H, Somnier F, Illes Z, Pinborg LH.

Eur J Neurol. 2017 Aug;24(8):999-1005. doi: 10.1111/ene.13324. Epub 2017 May 25.

PMID:
28544133
25.

Identification of a novel HLA-B allele, HLA-B*08:177, in a Hungarian patient and her HLA identical sibling.

Inotai D, Illés Z, Szabó E, Varga Á, Szilvási A.

HLA. 2017 Aug;90(2):113-114. doi: 10.1111/tan.13050. Epub 2017 May 2.

PMID:
28464478
26.

Global brain atrophy and metabolic dysfunction in LGI1 encephalitis: A prospective multimodal MRI study.

Szots M, Blaabjerg M, Orsi G, Iversen P, Kondziella D, Madsen CG, Garde E, Magnusson PO, Barsi P, Nagy F, Siebner HR, Illes Z.

J Neurol Sci. 2017 May 15;376:159-165. doi: 10.1016/j.jns.2017.03.020. Epub 2017 Mar 16.

PMID:
28431605
27.

Teriflunomide for multiple sclerosis in real-world setting.

Elkjaer ML, Molnar T, Illes Z.

Acta Neurol Scand. 2017 Nov;136(5):447-453. doi: 10.1111/ane.12755. Epub 2017 Mar 20.

PMID:
28321835
28.

An observational study of alemtuzumab following fingolimod for multiple sclerosis.

Willis M, Pearson O, Illes Z, Sejbaek T, Nielsen C, Duddy M, Petheram K, van Munster C, Killestein J, Malmeström C, Tallantyre E, Robertson N.

Neurol Neuroimmunol Neuroinflamm. 2017 Jan 10;4(2):e320. doi: 10.1212/NXI.0000000000000320. eCollection 2017 Mar.

29.

Practice effect in Symbol Digit Modalities Test in multiple sclerosis patients treated with natalizumab.

Roar M, Illes Z, Sejbaek T.

Mult Scler Relat Disord. 2016 Nov;10:116-122. doi: 10.1016/j.msard.2016.09.009. Epub 2016 Sep 28.

PMID:
27919477
30.

l-Arginine Pathway Metabolites Predict Need for Intra-operative Shunt During Carotid Endarterectomy.

Szabo P, Lantos J, Nagy L, Keki S, Volgyi E, Menyhei G, Illes Z, Molnar T.

Eur J Vasc Endovasc Surg. 2016 Dec;52(6):721-728. doi: 10.1016/j.ejvs.2016.10.008. Epub 2016 Nov 10.

31.

Four cases of GABAB receptor encephalitis.

Szőts M, Blaabjerg M, Kondziella D, Herceg M, Diószeghy P, Bajzik G, Berki T, Kálmán E, Nagy F, Illés Z.

Ideggyogy Sz. 2016 Jul 30;69(7-8):281-287. doi: 10.18071/isz.69.0281.

PMID:
29465894
32.

Correlation of the L-Arginine Pathway with Thrombo-Inflammation May Contribute to the Outcome of Acute Ischemic Stroke.

Molnar T, Pusch G, Nagy L, Keki S, Berki T, Illes Z.

J Stroke Cerebrovasc Dis. 2016 Aug;25(8):2055-60. doi: 10.1016/j.jstrokecerebrovasdis.2016.05.018. Epub 2016 Jun 1.

PMID:
27263035
33.

Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions.

Erdélyi-Bótor S, Komáromy H, Kamson DO, Kovács N, Perlaki G, Orsi G, Molnár T, Illes Z, Nagy L, Kéki S, Deli G, Bosnyák E, Trauninger A, Pfund Z.

Cephalalgia. 2017 May;37(6):571-580. doi: 10.1177/0333102416651454. Epub 2016 May 19.

PMID:
27206959
34.

Widespread inflammation in CLIPPERS syndrome indicated by autopsy and ultra-high-field 7T MRI.

Blaabjerg M, Ruprecht K, Sinnecker T, Kondziella D, Niendorf T, Kerrn-Jespersen BM, Lindelof M, Lassmann H, Kristensen BW, Paul F, Illes Z.

Neurol Neuroimmunol Neuroinflamm. 2016 Apr 20;3(3):e226. doi: 10.1212/NXI.0000000000000226. eCollection 2016 Jun.

35.

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.

Waters P, Reindl M, Saiz A, Schanda K, Tuller F, Kral V, Nytrova P, Sobek O, Nielsen HH, Barington T, Lillevang ST, Illes Z, Rentzsch K, Berthele A, Berki T, Granieri L, Bertolotto A, Giometto B, Zuliani L, Hamann D, van Pelt ED, Hintzen R, Höftberger R, Costa C, Comabella M, Montalban X, Tintoré M, Siva A, Altintas A, Deniz G, Woodhall M, Palace J, Paul F, Hartung HP, Aktas O, Jarius S, Wildemann B, Vedeler C, Ruiz A, Leite MI, Trillenberg P, Probst M, Saschenbrecker S, Vincent A, Marignier R.

J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):1005-15. doi: 10.1136/jnnp-2015-312601. Epub 2016 Apr 25.

36.

Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.

Oji S, Nicolussi EM, Kaufmann N, Zeka B, Schanda K, Fujihara K, Illes Z, Dahle C, Reindl M, Lassmann H, Bradl M.

PLoS One. 2016 Mar 18;11(3):e0151244. doi: 10.1371/journal.pone.0151244. eCollection 2016.

37.

In vivo imaging reveals rapid astrocyte depletion and axon damage in a model of neuromyelitis optica-related pathology.

Herwerth M, Kalluri SR, Srivastava R, Kleele T, Kenet S, Illes Z, Merkler D, Bennett JL, Misgeld T, Hemmer B.

Ann Neurol. 2016 May;79(5):794-805. doi: 10.1002/ana.24630. Epub 2016 Apr 18.

38.

[MENTALIZING DEFICIT IN NEUROLOGICAL DISORDERS: A REVIEW ARTICLE].

Herold R, Varga E, Mike A, Tényi T, Simon M, Hajnal A, Fekete S, Illés Z.

Ideggyogy Sz. 2015 Nov 30;68(11-12):364-73. Review. Hungarian.

PMID:
26821510
39.

A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica.

Gebregiworgis T, Nielsen HH, Massilamany C, Gangaplara A, Reddy J, Illes Z, Powers R.

J Proteome Res. 2016 Feb 5;15(2):659-66. doi: 10.1021/acs.jproteome.5b01111. Epub 2016 Jan 27.

40.

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.

Juryńczyk M, Weinshenker B, Akman-Demir G, Asgari N, Barnes D, Boggild M, Chaudhuri A, D'hooghe M, Evangelou N, Geraldes R, Illes Z, Jacob A, Kim HJ, Kleiter I, Levy M, Marignier R, McGuigan C, Murray K, Nakashima I, Pandit L, Paul F, Pittock S, Selmaj K, de Sèze J, Siva A, Tanasescu R, Vukusic S, Wingerchuk D, Wren D, Leite I, Palace J.

J Neurol. 2016 Jan;263(1):140-9. doi: 10.1007/s00415-015-7952-8. Epub 2015 Nov 3.

41.

Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS.

Zeka B, Hastermann M, Hochmeister S, Kögl N, Kaufmann N, Schanda K, Mader S, Misu T, Rommer P, Fujihara K, Illes Z, Leutmezer F, Sato DK, Nakashima I, Reindl M, Lassmann H, Bradl M.

Acta Neuropathol. 2015 Dec;130(6):783-98. doi: 10.1007/s00401-015-1501-5. Epub 2015 Nov 3.

42.

Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.

Kovacs KT, Kalluri SR, Boza-Serrano A, Deierborg T, Csepany T, Simo M, Rokusz L, Miseta A, Alcaraz N, Czirjak L, Berki T, Molnar T, Hemmer B, Illes Z.

Mult Scler. 2016 Aug;22(9):1192-201. doi: 10.1177/1352458515613165. Epub 2015 Oct 29.

PMID:
26514978
43.

L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker.

Ruzsics I, Nagy L, Keki S, Sarosi V, Illes B, Illes Z, Horvath I, Bogar L, Molnar T.

COPD. 2016;13(2):139-45. doi: 10.3109/15412555.2015.1045973. Epub 2015 Oct 29.

PMID:
26514682
44.

The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study.

Nielsen HH, Beck HC, Kristensen LP, Burton M, Csepany T, Simo M, Dioszeghy P, Sejbaek T, Grebing M, Heegaard NH, Illes Z.

PLoS One. 2015 Oct 13;10(10):e0139659. doi: 10.1371/journal.pone.0139659. eCollection 2015.

45.

[LGI1 ENCEPHALITIS: THE FIRST HUNGARIAN PATIENT].

Szőts M, Marton A, Illés Z, Bajzik G, Nagy F.

Ideggyogy Sz. 2015 Jul 30;68(7-8):279-85. Review. Hungarian.

PMID:
26380423
46.

Feto-maternal immune regulation by TIM-3/galectin-9 pathway and PD-1 molecule in mice at day 14.5 of pregnancy.

Meggyes M, Lajko A, Palkovics T, Totsimon A, Illes Z, Szereday L, Miko E.

Placenta. 2015 Oct;36(10):1153-60. doi: 10.1016/j.placenta.2015.07.124. Epub 2015 Jul 18.

PMID:
26278059
47.

[ALEMTUZUMAB: BENEFITS AND CHALLENGES OF A NEW THERAPY IN MULTIPLE SCLEROSIS].

Illés Z, Sejbaek T, Csépány T.

Ideggyogy Sz. 2015 May 30;68(5-6):155-64. Review. Hungarian.

PMID:
26182606
48.

HLA genetic diversity in Hungarians and Hungarian Gypsies: complementary differentiation patterns and demographic signals revealed by HLA-A, -B and -DRB1 in Central Europe.

Inotai D, Szilvasi A, Benko S, Boros-Major A, Illes Z, Bors A, Kiss KP, Rajczy K, Gelle-Hossó A, Buhler S, Nunes JM, Sanchez-Mazas A, Tordai A.

Tissue Antigens. 2015 Aug;86(2):115-21. doi: 10.1111/tan.12600. Epub 2015 Jul 7.

PMID:
26149581
49.

Thymic Atrophy and Apoptosis of CD4+CD8+ Thymocytes in the Cuprizone Model of Multiple Sclerosis.

Solti I, Kvell K, Talaber G, Veto S, Acs P, Gallyas F Jr, Illes Z, Fekete K, Zalan P, Szanto A, Bognar Z.

PLoS One. 2015 Jun 8;10(6):e0129217. doi: 10.1371/journal.pone.0129217. eCollection 2015.

50.

Early Dynamics of P-selectin and Interleukin 6 Predicts Outcomes in Ischemic Stroke.

Pusch G, Debrabant B, Molnar T, Feher G, Papp V, Banati M, Kovacs N, Szapary L, Illes Z.

J Stroke Cerebrovasc Dis. 2015 Aug;24(8):1938-47. doi: 10.1016/j.jstrokecerebrovasdis.2015.05.005. Epub 2015 Jun 4.

PMID:
26051664

Supplemental Content

Support Center